These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 9038613

  • 21. A population-based study of the usefulness of screening for neuroblastoma.
    Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Byrne T, Weitzman S, Bunin G, Lemieux B.
    Lancet; ; 348(9043):1682-7. PubMed ID: 8973429
    [Abstract] [Full Text] [Related]

  • 22. Different characteristics of neuroblastomas in cases found by mass screening and non-screening: evaluation of mass screening for neuroblastoma in Kitakyushu City.
    Ariyoshi N.
    J UOEH; 1993 Dec 01; 15(4):251-66. PubMed ID: 8265887
    [Abstract] [Full Text] [Related]

  • 23. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
    Nakagawara A, Zaizen Y, Ikeda K, Suita S, Ohgami H, Nagahara N, Sera Y, Akiyama H, Kawakami K, Uchino J.
    Cancer; 1991 Nov 01; 68(9):2037-44. PubMed ID: 1913552
    [Abstract] [Full Text] [Related]

  • 24. Screening for neuroblastoma is ineffective in reducing the incidence of unfavourable advanced stage disease in older children.
    Woods WG, Tuchman M, Robison LL, Bernstein M, Leclerc JM, Brisson LC, Brossard J, Hill G, Shuster J, Luepker R, Byrne T, Weitzman S, Bunin G, Lemieux B, Brodeur GM.
    Eur J Cancer; 1997 Oct 01; 33(12):2106-12. PubMed ID: 9516863
    [Abstract] [Full Text] [Related]

  • 25. 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).
    Erttmann R, Tafese T, Berthold F, Kerbl R, Mann J, Parker L, Schilling F, Ambros P, Christiansen H, Favrot M, Kabisch H, Hero B, Philip T.
    Eur J Cancer; 1998 Aug 01; 34(9):1391-7. PubMed ID: 9849422
    [Abstract] [Full Text] [Related]

  • 26. Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children.
    Bessho F, Hashizume K, Nakajo T, Kamoshita S.
    J Pediatr; 1991 Aug 01; 119(2):237-41. PubMed ID: 1861208
    [Abstract] [Full Text] [Related]

  • 27. Neuroblastoma mass screening: the arguments for and against.
    Treuner J, Schilling FH.
    Eur J Cancer; 1995 Aug 01; 31A(4):565-8. PubMed ID: 7576969
    [Abstract] [Full Text] [Related]

  • 28. Feasibility of chemical screening of urine for neuroblastoma case finding in infancy in Quebec.
    Scriver CR, Gregory D, Bernstein M, Clow CL, Weisdorf T, Dougherty GE, Auray-Blais C, Giguère R, Lemieux B, Laberge C.
    CMAJ; 1987 May 01; 136(9):952-6. PubMed ID: 3105859
    [Abstract] [Full Text] [Related]

  • 29. Mass screening for neuroblastoma and mortality in birth cohorts.
    Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Takasugi N.
    Int J Cancer; 1997 May 16; 71(4):552-5. PubMed ID: 9178807
    [Abstract] [Full Text] [Related]

  • 30. Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.
    Kaneko Y, Kanda N, Maseki N, Nakachi K, Takeda T, Okabe I, Sakurai M.
    J Clin Oncol; 1990 Dec 16; 8(12):2005-13. PubMed ID: 2230892
    [Abstract] [Full Text] [Related]

  • 31. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S, Zaizen Y, Sera Y, Takamatsu H, Mizote H, Ohgami H, Kurosaki N, Ueda K, Tasaka H, Miyazaki S, Sugimoto T, Kawakami K, Tsuneyoshi M, Yano H, Akiyama H, Ikeda K.
    J Pediatr Surg; 1996 Apr 16; 31(4):555-8. PubMed ID: 8801312
    [Abstract] [Full Text] [Related]

  • 32. Mass screening of neuroblastoma in Sapporo City, Japan.
    Nishi M, Miyake H, Takeda T, Kikuchi Y, Hanai J, Yonemori H, Takasugi N.
    Am J Pediatr Hematol Oncol; 1992 Nov 16; 14(4):327-31. PubMed ID: 1456398
    [Abstract] [Full Text] [Related]

  • 33. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
    Ater JL, Gardner KL, Foxhall LE, Therrell BL, Bleyer WA.
    Cancer; 1998 Apr 15; 82(8):1593-602. PubMed ID: 9554539
    [Abstract] [Full Text] [Related]

  • 34. A pilot study of screening for neuroblastoma in the north of England.
    Craft AW, Parker L, Dale G, McGill AC, Seviour JA, Bell S, Cole M, Smith J.
    Am J Pediatr Hematol Oncol; 1992 Nov 15; 14(4):337-41. PubMed ID: 1456400
    [Abstract] [Full Text] [Related]

  • 35. Compliance in a screening program for neuroblastoma.
    Campion P, Woods WG, Lemieux B.
    Prev Med; 1998 Nov 15; 27(4):590-6. PubMed ID: 9672953
    [Abstract] [Full Text] [Related]

  • 36. Problems of mass screening for neuroblastoma: analysis of false-negative cases.
    Ishimoto K, Kiyokawa N, Fujita H, Yabuta K, Ohya T, Miyano T, Shinohara T, Sera Y.
    J Pediatr Surg; 1990 Apr 15; 25(4):398-401. PubMed ID: 2329455
    [Abstract] [Full Text] [Related]

  • 37. Use of a test diet in screening for neuroblastoma reduces false-positives attributable to food intake.
    Saito T, Nikkawa T, Usugane T, Okamoto T, Komiya H.
    Acta Paediatr Scand; 1990 Oct 15; 79(10):943-9. PubMed ID: 2264466
    [Abstract] [Full Text] [Related]

  • 38. Screening for neuroblastoma.
    Huddart SN, Mann JR.
    Arch Dis Child; 1991 Nov 15; 66(11):1272-4. PubMed ID: 1755635
    [No Abstract] [Full Text] [Related]

  • 39. Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim results.
    Schilling FH, Berthold F, Erttmann R, Michaelis J, Spix C, Sander J, Schwarz K, Treuner J.
    Med Pediatr Oncol; 2000 Dec 15; 35(6):701-4. PubMed ID: 11107150
    [Abstract] [Full Text] [Related]

  • 40. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T, Kidowaki T, Sakamoto I, Hashida T, Matsumura T, Nakagawa M, Kusunoki T.
    Cancer; 1984 Jun 15; 53(12):2731-5. PubMed ID: 6722733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.